Jennison Associates’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,720,838
| Closed | -$8.91M | – | 822 |
|
|
2016
Q4 | $8.91M | Buy |
1,720,838
+4,988
| +0.3% | +$25.8K | 0.01% | 481 |
|
|
2016
Q3 | $9.56M | Sell |
1,715,850
-39,185
| -2% | -$218K | 0.01% | 474 |
|
|
2016
Q2 | $9.74M | Sell |
1,755,035
-6,009
| -0.3% | -$33.3K | 0.01% | 457 |
|
|
2016
Q1 | $7.75M | Buy |
1,761,044
+12,932
| +0.7% | +$56.9K | 0.01% | 465 |
|
|
2015
Q4 | $10.5M | Buy |
1,748,112
+906,153
| +108% | +$5.46M | 0.01% | 474 |
|
|
2015
Q3 | $6.58M | Buy |
841,959
+165,089
| +24% | +$1.29M | 0.01% | 520 |
|
|
2015
Q2 | $4.15M | Sell |
676,870
-291,922
| -30% | -$1.79M | ﹤0.01% | 539 |
|
|
2015
Q1 | $7.8M | Sell |
968,792
-12,400
| -1% | -$99.8K | 0.01% | 494 |
|
|
2014
Q4 | $4.97M | Buy |
+981,192
| New | +$4.97M | ﹤0.01% | 509 |
|